美股市场个股详情

SLN Silence Therapeutics

添加自选

21.950
+0.345+1.60%

交易中 04/29 14:22 (美东)

10.23亿总市值-15054市盈率TTM

Silence Therapeutics股票讨论区

登录发表评论

Moomoo AI

02/03 20:08

Despite strong growth, Silence Therapeutics' high P/S ratio and weak revenue outlook suggest a risk of share price decline. Analysts lack confidence in a business turnaround, indicating potential risk for shareholders and potential investors.

Optimistic Investors Push Silence Therapeutics Plc (NASDAQ:SLN) Shares Up 26% But Growth Is Lacking

Moomoo AI

2023/11/27 18:17

Analysts' confidence appears low for Silence Therapeutics' business turnaround. The high P/S ratio and expected revenue decline suggest unsustainable current price levels which may erode current sentiment towards the stock.

Optimistic Investors Push Silence Therapeutics Plc (NASDAQ:SLN) Shares Up 65% But Growth Is Lacking

Trytosaveabit

2023/11/01 19:13

News

$Silence Therapeutics(SLN.US)$ Silence Therapeutics Reports Topline Results From Phase 1 Multiple Dose Study Of Zerlasiran; Lp(a) Levels Remained Around 90% Lower Than Baseline At Study Endpoint